These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1695192

  • 1. [Anti-allergic effects of tazanolast [butyl 3'-(1H-tetrazol-5-yl) oxanilate, WP-833] metabolites].
    Hashimoto T, Edanami K, Naito A, Sano K, Fushimi H, Goto M.
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):159-66. PubMed ID: 1695192
    [Abstract] [Full Text] [Related]

  • 2. Effect of butyl 3-(1H-tetrazol-5-Yl) oxanilate (MTB) on immunological or non-immunological histamine and SRS(-A) release from guinea-pig, monkey and human lung tissue.
    Hashimoto T, Kohno SW, Ohata K, Yanagihara Y, Shida T.
    Jpn J Pharmacol; 1987 Aug; 44(4):447-53. PubMed ID: 2446036
    [Abstract] [Full Text] [Related]

  • 3. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
    Yanagihara Y, Abe T, Edanami K, Agata M, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
    [Abstract] [Full Text] [Related]

  • 4. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 3rd communication: inhibitory effects on histamine release from lung fragments, Schultz-Dale reaction in isolated tracheal muscle and experimental asthma in guinea pigs.
    Yanagihara Y, Abe T, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):80-3. PubMed ID: 2452640
    [Abstract] [Full Text] [Related]

  • 5. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 2nd communication: inhibitory effects on histamine release from rat mast cells and lung fragments.
    Yanagihara Y, Abe T, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):75-9. PubMed ID: 2452639
    [Abstract] [Full Text] [Related]

  • 6. Effect of an active metabolite of the antiallergic agent tazanolast on histamine release from rat mast cells.
    Kamei C, Mio M, Yoshida T, Saito Y, Toyoda Y, Tsuriya Y.
    Arzneimittelforschung; 1997 Apr; 47(4):390-4. PubMed ID: 9150859
    [Abstract] [Full Text] [Related]

  • 7. Antiallergic properties of an orally effective agent, [[3-(1H-tetrazol-5-yl)-phenyl] amino] oxoacetic acid n-butyl ester.
    Agata M, Goto H, Tsuriya Y, Tachibana K, Kuroda T.
    Jpn J Pharmacol; 1982 Aug; 32(4):689-97. PubMed ID: 6182323
    [Abstract] [Full Text] [Related]

  • 8. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T, Yamamura H, Kohno S, Ohata K.
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [Abstract] [Full Text] [Related]

  • 9. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 4th communication: effects on histamine release from human leukocytes and from human and monkey lung fragments.
    Yanagihara Y, Abe T, Tsuriya Y, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):84-7. PubMed ID: 2452641
    [Abstract] [Full Text] [Related]

  • 10. Potent inhibitory activity of HSR-6071, a new antiallergic agent, on passive cutaneous anaphylaxis (PCA).
    Makino E, Ohashi T, Takahashi H, Kato H, Ito Y, Nagai H, Koda A, Azuma H.
    Jpn J Pharmacol; 1990 Jan; 52(1):87-94. PubMed ID: 1689783
    [Abstract] [Full Text] [Related]

  • 11. Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-bu tyric acid.
    Kuriyama K, Hiyama Y, Ito K.
    Jpn J Pharmacol; 1989 Jun; 50(2):111-8. PubMed ID: 2475659
    [Abstract] [Full Text] [Related]

  • 12. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.
    Kobayashi K, Hiroi J, Kishi S, Sawase K, Hirayama Y, Chihara S, Imai T, Shigi Y, Shimomura K, Kohsaka M.
    Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860
    [Abstract] [Full Text] [Related]

  • 13. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
    Koda A, Nagai H, Mori H, Inagaki N, Nishiyori T, Matsuura N, Iwamoto T, Furukawa K, Yamada H, Goto S.
    Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
    [Abstract] [Full Text] [Related]

  • 14. CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the topical treatment of asthma.
    Revel L, Colombo S, Ferrari F, Folco G, Rovati LC, Makovec F.
    Eur J Pharmacol; 1992 Dec 08; 229(1):45-53. PubMed ID: 1282105
    [Abstract] [Full Text] [Related]

  • 15. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
    Yamamura H, Kohno S, Ohata K.
    Arerugi; 1991 Jul 08; 40(7):669-79. PubMed ID: 1718245
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs.
    Makino E, Ohashi T, Takahashi H, Kato H, Ito Y, Nagai H, Koda A, Azuma H.
    J Pharm Pharmacol; 1990 Apr 08; 42(4):236-41. PubMed ID: 1974289
    [Abstract] [Full Text] [Related]

  • 17. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K, Akagi M, Izushi K, Mio M.
    Methods Find Exp Clin Pharmacol; 1990 Oct 08; 12(8):531-9. PubMed ID: 1709434
    [Abstract] [Full Text] [Related]

  • 18. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H, Suda H, Kitagaki K, Goto S, Miura T, Koda A.
    Arch Int Pharmacodyn Ther; 1990 Oct 08; 307():172-82. PubMed ID: 1710442
    [Abstract] [Full Text] [Related]

  • 19. [Anti-allergic effects of (E)-3-[p-(1H-imidazol-1-lylmethyl) phenyl]-2-propenoic acid (OKY-046), a specific thromboxane (TX) A2 synthetase inhibitor: effects on type I allergic reactions].
    Takehana Y, Kikuchi S, Hara K, Hamano S, Komatsu H, Ujiie A, Okegawa T, Ikeda S.
    Nihon Yakurigaku Zasshi; 1990 Mar 08; 95(3):121-30. PubMed ID: 1693906
    [Abstract] [Full Text] [Related]

  • 20. [The pharmacological properties of a new anti-allergic agent, KP-136, in cutaneous models].
    Kuriyama K, Hiyama Y, Ito K, Ichikawa K, Kitada S, Yoshinaka I.
    Nihon Yakurigaku Zasshi; 1987 Apr 08; 89(4):213-24. PubMed ID: 2440785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.